181.47
price down icon3.86%   -7.29
after-market Handel nachbörslich: 181.47
loading
Schlusskurs vom Vortag:
$188.76
Offen:
$189.88
24-Stunden-Volumen:
314.38K
Relative Volume:
0.91
Marktkapitalisierung:
$5.25B
Einnahmen:
$290.51M
Nettoeinkommen (Verlust:
$89.16M
KGV:
60.69
EPS:
2.99
Netto-Cashflow:
$119.18M
1W Leistung:
-1.03%
1M Leistung:
+32.02%
6M Leistung:
+12.96%
1J Leistung:
+4.81%
1-Tages-Spanne:
Value
$181.32
$190.01
1-Wochen-Bereich:
Value
$179.80
$190.01
52-Wochen-Spanne:
Value
$122.80
$207.84

Krystal Biotech Inc Stock (KRYS) Company Profile

Name
Firmenname
Krystal Biotech Inc
Name
Telefon
(412) 586-5830
Name
Adresse
2100 WHARTON STREET, PITTSBURGH, PA
Name
Mitarbeiter
275
Name
Twitter
@KrystalBiotech
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
KRYS's Discussions on Twitter

Vergleichen Sie KRYS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
KRYS
Krystal Biotech Inc
181.47 5.46B 290.51M 89.16M 119.18M 2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-05 Eingeleitet Jefferies Buy
2024-08-06 Herabstufung Citigroup Buy → Neutral
2023-11-20 Eingeleitet Goldman Buy
2023-10-24 Eingeleitet Cantor Fitzgerald Overweight
2023-10-12 Eingeleitet Citigroup Buy
2023-09-07 Eingeleitet Berenberg Buy
2023-04-18 Eingeleitet Stifel Buy
2023-02-28 Hochstufung Goldman Neutral → Buy
2022-08-25 Herabstufung Goldman Buy → Neutral
2022-01-18 Eingeleitet BofA Securities Buy
2021-07-20 Hochstufung Goldman Neutral → Buy
2020-09-18 Eingeleitet B. Riley FBR Buy
2020-06-04 Eingeleitet Evercore ISI Outperform
2019-09-24 Eingeleitet Goldman Neutral
2019-08-06 Bestätigt H.C. Wainwright Buy
2019-06-24 Bestätigt Chardan Capital Markets Buy
2019-06-24 Bestätigt H.C. Wainwright Buy
2019-05-30 Eingeleitet Guggenheim Buy
2018-09-11 Eingeleitet Cantor Fitzgerald Overweight
Alle ansehen

Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten

pulisher
04:53 AM

Will Krystal Biotech Inc. (4KB) stock outperform Dow Jones2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com

04:53 AM
pulisher
03:00 AM

What machine learning models say about Krystal Biotech Inc.2025 Support & Resistance & Short-Term High Return Ideas - newser.com

03:00 AM
pulisher
Oct 11, 2025

Is Krystal Biotech Inc 4KB a good long term investmentCandlestick Trading Patterns & Budget Investment Success - earlytimes.in

Oct 11, 2025
pulisher
Oct 10, 2025

I See Some Speculative Wins Starting to Krystal-ize - TheStreet Pro

Oct 10, 2025
pulisher
Oct 10, 2025

What high frequency data says about Krystal Biotech Inc.2025 Momentum Check & Fast Gain Stock Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 04:55:37 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Krystal Biotech Inc. stock outlook for YEARMarket Growth Summary & Stock Portfolio Risk Control - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Market Participants Recognise Krystal Biotech, Inc.'s (NASDAQ:KRYS) Earnings Pushing Shares 29% Higher - simplywall.st

Oct 09, 2025
pulisher
Oct 09, 2025

Sentiment analysis tools applied to Krystal Biotech Inc.Trade Exit Report & Technical Entry and Exit Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

How Krystal Biotech Inc. stock reacts to Fed rate cutsCEO Change & AI Forecasted Entry/Exit Points - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Krystal Biotech Inc. (4KB) stock a buy for dividend portfoliosTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

How Krystal Biotech Inc. (4KB) stock reacts to monetary easingTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Will Krystal Biotech Inc. (4KB) stock see valuation expansionTrend Reversal & Safe Capital Growth Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What’s the recovery path for long term holders of Krystal Biotech Inc.Weekly Trading Summary & Community Verified Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Krystal Biotech Inc. (4KB) stock worth buying before Fed action2025 Dividend Review & Risk Managed Investment Strategies - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Krystal Biotech Hits Day High with 9.54% Surge in Strong Performance - Markets Mojo

Oct 03, 2025
pulisher
Oct 03, 2025

Signal strength of Krystal Biotech Inc. stock in tech scannersJuly 2025 Highlights & Capital Protection Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Applying Elliott Wave Theory to Krystal Biotech Inc.Trade Risk Summary & Real-Time Chart Pattern Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Analyzing drawdowns of Krystal Biotech Inc. with statistical toolsSell Signal & Weekly Return Optimization Alerts - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Exploring 3 High Growth Tech Stocks in the US Market - Yahoo Finance

Oct 02, 2025
pulisher
Oct 01, 2025

Krystal Biotech's Heavy Reliance on Vyjuvek: Growth Driver or Risk Factor? - MSN

Oct 01, 2025
pulisher
Oct 01, 2025

Krystal Biotech Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 01, 2025
pulisher
Oct 01, 2025

6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner - Sahm

Oct 01, 2025
pulisher
Sep 30, 2025

Tealwood Asset Management Inc. Invests $1.13 Million in Krystal Biotech, Inc. $KRYS - MarketBeat

Sep 30, 2025
pulisher
Sep 29, 2025

Krystal Biotech, Inc. (KRYS) Stock Analysis: Uncovering a 22% Upside Potential Amidst Robust Revenue Growth - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Potential 22% Upside with Strong Buy Ratings - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Tempus Wealth Planning LLC Takes Position in Krystal Biotech, Inc. $KRYS - MarketBeat

Sep 29, 2025
pulisher
Sep 28, 2025

Should You Invest in BLS Infotech Limited Before Its Next Earnings ReportPrice-to-Earnings Ratio Insights & High Yield Portfolio Growth - earlytimes.in

Sep 28, 2025

Finanzdaten der Krystal Biotech Inc-Aktie (KRYS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Krystal Biotech Inc-Aktie (KRYS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Krishnan Suma
President, R&D
Jul 14 '25
Sale
150.30
13,400
2,014,015
1,512,529
Krishnan Suma
President, R&D
Jul 15 '25
Sale
151.01
3,084
465,700
1,509,445
Krishnan Suma
President, R&D
Jul 15 '25
Sale
150.98
3,036
458,361
1,440,240
Krishnan Suma
President, R&D
Jul 16 '25
Sale
150.00
1,529
229,350
1,438,711
Krishnan Suma
President, R&D
Jul 16 '25
Sale
150.00
1,389
208,350
1,508,056
Krishnan Krish S
President and CEO
Jul 14 '25
Sale
150.30
13,435
2,019,225
1,443,276
Krishnan Krish S
President and CEO
Jul 14 '25
Sale
150.30
13,400
2,014,015
1,512,529
Krishnan Krish S
President and CEO
Jul 15 '25
Sale
151.01
3,084
465,700
1,509,445
Krishnan Krish S
President and CEO
Jul 15 '25
Sale
150.98
3,036
458,361
1,440,240
Krishnan Krish S
President and CEO
Jul 16 '25
Sale
150.00
1,529
229,350
1,438,711
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):